Paulson & Co’s PharMerica Corporation PMC Stock Holding History

Paulson & Co’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-496,000	Closed	-$17.4M	–	105
2015 Q4	$17.4M	Buy	496,000 +46,000	+10%	+$1.44M	0.1%	45
2015 Q3	$12.8M	Sell	450,000 -50,000	-10%	-$1.68M	0.07%	55
2015 Q2	$16.6M	Buy	+500,000	New	+$15.3M	0.08%	51

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCP

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Paulson & Co's PMC Position: Q1 2016 in Review

Paulson & Co sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 496,000 shares — an estimated $17.4M sold.

Paulson & Co first reported a position in PMC in Q2 2015 and held it in 3 quarters. The position peaked at $17.4M in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

Paulson & Co reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
Paulson & Co sold 496,000 PharMerica Corporation shares in Q1 2016, an estimated $17.4M.
Paulson & Co first reported a position in PharMerica Corporation in Q2 2015 and held it in 3 quarters.
Paulson & Co's PharMerica Corporation position peaked at $17.4M in Q4 2015.
169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.